APICES

Pinto, Spain Founded: 2009 • Age: 17 yrs Acquired By Magnum Partners
Diversified CRO services are provided to clients in the sector.

About APICES

APICES is a Healthcare company based in Pinto (Spain) founded in 2009, and was acquired by Magnum Partners in November 2021. Diversified CRO services are provided to clients in the sector. Its chief executive, as recorded, is Oscar Salamanca. APICES offers products and services including Biostatistics, Pharmacovigilance, Data Management, and Project Design. Its focus areas include Biopharma Outsourcing, CRO and Diversified.

Company details

APICES was established in 2009 and is based in Pinto, Spain. Operations focus on the contract research organization sector, where a range of diversified services is delivered to support research and development needs. The company operates within the biotechnology and pharmaceutical industries, offering expertise in clinical and preclinical activities. Leadership is provided by CEO Oscar Salamanca, with services tailored to international clients from the Spanish headquarters.

  • Headquarters Pinto, Spain
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website apices.es
  • Social LinkedIn X
  • Acquired by Magnum Partners (Nov 2021)
Key Metrics

Products & Services of APICES

APICES offers a comprehensive portfolio of products and services, including Biostatistics, Pharmacovigilance, Data Management, and Project Design.

Biostatistics
Data Analysis

Provides statistical support for clinical studies and trials.

Pharmacovigilance
Safety Monitoring

Manages drug safety and adverse event reporting in research.

Data Management
Data Handling

Tailors data services for efficient clinical study needs.

Project Design
Planning Services

Handles project definition and site selection for trials.

Funding Insights of APICES

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of APICES with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2016Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in APICES

APICES has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Magnum Industrial Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
A leading private equity firm focused on Iberian markets is operated.
2006magnumpartners.comMadrid, Spain
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for APICES

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of APICES

4 people are tracked at APICES (3 in leadership, 1 in team).

NameRoleGroup
Oscar Salamanca
CEOLeadership
Egle Pavyde
Vice President Of Business DevelopmentLeadership
Ana María Moreno Fernández
Director Global Clinical OperationsLeadership
Laura Redondo Sánchez
Data Manager And BiostatisticianTeam
Premium access

Complete people profiles for APICES

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of APICES

3 dated milestones of APICES across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded APICES is founded.
  2. Funding First funding round.
  3. Exit Acquired by Magnum Partners.

Web traffic of APICES

The website of APICES (apices.es) receives about 1.7K visits a month.

  • Monthly visits
    1.7K

    ▲ 73.4% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Apices

Premium access

Complete news archive for APICES

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about APICES

APICES was founded in 2009 and raised its 1st funding round 7 years after it was founded.

APICES is headquartered in Pinto, Spain. It is registered at Pinto, Madrid, Spain.

Oscar Salamanca is the CEO of APICES, as recorded in our data.

APICES was established in 2009 and is based in Pinto, Spain. Operations focus on the contract research organization sector, where a range of diversified services is delivered to support research and development needs. The company operates within the biotechnology and pharmaceutical industries, offering expertise in clinical and preclinical activities. Leadership is provided by CEO Oscar Salamanca, with services tailored to international clients from the Spanish headquarters.

APICES offers Biostatistics, Pharmacovigilance, Data Management, and Project Design.

APICES has 2 investors. Key investors include European Union, and Magnum Industrial Partners.

Yes. APICES was acquired by Magnum Partners in November 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available